Tired of healthcare systems that only react to disease? Axo Longevity, a company building tools to spot and prevent illnesses before they take hold, has closed a $5.0M Seed funding round. The capital will fuel its efforts to move beyond the current model of waiting for sickness to appear, aiming for a more proactive and efficient approach to health.
The investment round drew support from a broad syndicate of backers, including MS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital, NIAN Sports & Entertainment, Dr. Jorge Planas, and Daniel Kulle. This diverse group is betting on Axo Longevity's vision to transform how individuals manage their long-term health.
